By combining bioinformatic analysis and laboratory experiments, the characteristics of PD-L1 were presented in a systematic manner by the pan-cancer study in a number of areas, such as expression pattern, genetic mutation, survival prognosis, MSI, TMB, MMR, tumor immune micro milieu, medication sensitivity, and signaling pathway. The gene discussed is CD274; the disease is cancer.